Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging
Background: Neoadjuvant chemotherapy (NAC) improves survival in responder patients. However, for non-responders, the treatment represents an ineffective exposure to chemotherapy and its potential adverse events. Predicting the response to treatment is a major issue in the therapeutic management of p...
Main Authors: | Camille Mazza, Vincent Gaydou, Jean-Christophe Eymard, Philippe Birembaut, Valérie Untereiner, Jean-François Côté, Isabelle Brocheriou, David Coeffic, Philippe Villena, Stéphane Larré, Vincent Vuiblet, Olivier Piot |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/1/21 |
Similar Items
-
Neoadjuvant treatment for pancreatic cancer: Controversies and advances
by: Douglas Dias e Silva, et al.
Published: (2024-01-01) -
Neoadjuvant chemotherapy may be the best neoadjuvant therapy modality for non-metastatic pancreatic cancer: a population based study
by: Jie Yang, et al.
Published: (2024-04-01) -
Neoadjuvant Systemic Treatment of Primary Angiosarcoma
by: Kimberley M. Heinhuis, et al.
Published: (2020-08-01) -
Survival Outcomes of Patients with Locally Advanced Breast Cancer after Neoadjuvant Systemic Therapy in St. Luke’s Medical Center
by: Cristina G. Domingo, et al.
Published: (2023-05-01) -
Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: Alimoghadam K, et al.
Published: (2004-07-01)